Please use this identifier to cite or link to this item: https://doi.org/10.1002/ijc.26120
Title: Inhibition of CXCR4/CXCL12 signaling axis by ursolic acid leads to suppression of metastasis in transgenic adenocarcinoma of mouse prostate model
Authors: Shanmugam, M.K. 
Manu, K.A. 
Ong, T.H.
Ramachandran, L.
Surana, R.
Bist, P.
Lim, L.H.K.
Prem Kumar, A. 
Hui, K.M.
Sethi, G.
Keywords: CXCR4
invasion
metastasis
prostate cancer
TRAMP
ursolic acid
Issue Date: 1-Oct-2011
Citation: Shanmugam, M.K., Manu, K.A., Ong, T.H., Ramachandran, L., Surana, R., Bist, P., Lim, L.H.K., Prem Kumar, A., Hui, K.M., Sethi, G. (2011-10-01). Inhibition of CXCR4/CXCL12 signaling axis by ursolic acid leads to suppression of metastasis in transgenic adenocarcinoma of mouse prostate model. International Journal of Cancer 129 (7) : 1552-1563. ScholarBank@NUS Repository. https://doi.org/10.1002/ijc.26120
Abstract: Increasing evidences indicate that CXCR4/CXCL12 signaling pathway plays a pivotal role in the process of distant site metastasis that accounts for more than 90% of prostate cancer related deaths in patients. Thus, novel drugs that can downregulate CXCR4/CXCL12 axis have a great potential in the treatment of metastatic prostate cancer. In this report, we tested an agent, ursolic acid (UA) for its ability to modulate CXCR4 expression in prostate cancer cell lines and inhibit metastasis in vivo in transgenic adenocarcinoma of mouse prostate (TRAMP) model. We observed that UA downregulated the expression of CXCR4 in prostate cancer cells irrespective of their HER2 status in a dose- and time-dependent manner. Neither proteasome inhibitor nor lysosomal stabilization had any effect on UA-induced decrease in CXCR4 expression. When investigated for the molecular mechanisms, it was observed that the downregulation of CXCR4 was due to transcriptional regulation as indicated by downregulation of mRNA expression, inhibition of NF-κB activation and modulation of chromatin immunoprecipitation activity. Suppression of CXCR4 expression by UA further correlated with the inhibition of CXCL12-induced migration and invasion in prostate cancer cells. Finally, we also found that UA treatment can inhibit metastasis of prostate cancer to distal organs, including lung and liver and suppress CXCR4 expression levels in the prostate tissues of TRAMP mice. Overall, our experimental findings suggest that UA exerts its antimetastatic effects through the suppression of CXCR4 expression in prostate cancer both in vitro and in vivo. Copyright © 2011 UICC.
Source Title: International Journal of Cancer
URI: http://scholarbank.nus.edu.sg/handle/10635/108435
ISSN: 00207136
DOI: 10.1002/ijc.26120
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

65
checked on Aug 20, 2019

WEB OF SCIENCETM
Citations

64
checked on Aug 12, 2019

Page view(s)

35
checked on Aug 16, 2019

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.